fullscreen

eFinder

eFinder

Home › Pharmaceutical Intervention › Article

Merck exec says company is discussing use of Covid antiviral drug in Ebola response

Dailydispatch · 🇿🇦 public South Africa · · 297 words · By Reuters Agency
Pharmaceutical Intervention Public Health Crisis
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about Pharmaceutical Intervention

Merck is in discussions with various global health authorities about making its Covid antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic Republic of the Congo (DRC), a senior executive told Reuters.

Claims checked 10
Techniques found 1
Topics 2

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center75%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Merck is in discussions with various global health authorities about making its Covid antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic Republic of the Congo (DRC), a senior executive told Reuters.

Why it matters

The outbreak, which has so far infected a suspected 1,100 people and resulted in 42 confirmed deaths, involves a rare strain of the virus called Bundibugyo for which there are no approved vaccines or treatments.

Common ground

“Molnupiravir is a non-specific RNA virus drug.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

open_in_new Read the original article: https://www.dailydispatch.co.za/news/2026-06-02-merck-exec-says-company-is-discu…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 10 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4
verified Verified By Reference 3
verified Verified 2
info Single Source 1
check_circle
Claim 1: “for which there are no approved vaccines or treatments [Bundibugyo strain]”
CORROBORATED
Five independent news sources (Deutsche Welle, NBC Washington, NY Post, France24, The Guardian) all explicitly state that the Bundibugyo strain has no approved vaccines or treatments.
menu_book
wikipedia NEUTRAL — Bundibugyo virus (BDBV) is a species of ebolavirus that is closely related to the Zaire ebolavirus (EBOV). The virus is one of several that can cause Ebola disease in humans, taking the form of viral …
https://en.wikipedia.org/wiki/Bundibugyo_ebolavirus
menu_book
wikipedia NEUTRAL — Bundibugyo is a town in the Western Region of Uganda. It is the chief town of Bundibugyo District and the district headquarters are located there.
https://en.wikipedia.org/wiki/Bundibugyo
menu_book
wikipedia NEUTRAL — In May 2026, an epidemic of Ebola was reported in the Ituri Province of the Democratic Republic of the Congo (DRC). It is the 17th Ebola outbreak in the DRC and began only five months after the end of…
https://en.wikipedia.org/wiki/2026_Ebola_epidemic
+ 5 more evidence sources
verified
Claim 2: “The pill, developed by the New Jersey-based drugmaker along with Ridgeback Biotherapeutics and sold under the brand Lagevrio, was approved for emergency use by the Food and Drug Administration during the pandemic for mild-to-moderate Covid-19 in adults at high risk for severe disease”
VERIFIED BY REFERENCE
Wikipedia and other medical/regulatory sources confirm Lagevrio (molnupiravir) was developed by Merck/Ridgeback and received FDA emergency use authorization for high-risk adults with mild-to-moderate COVID-19.
menu_book
wikipedia NEUTRAL — Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID‑19 in those infected by SARS-CoV-2. It is t…
https://en.wikipedia.org/wiki/Molnupiravir
menu_book
wikipedia NEUTRAL — COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 throu…
https://en.wikipedia.org/wiki/COVID-19_drug_development
travel_explore
web search NEUTRAL — The emergency use authorization was only narrowly approved (13–10) because of questions about efficacy and concerns that molnupiravir's mutagenic effects could ...
https://en.wikipedia.org/wiki/Molnupiravir
+ 2 more evidence sources
verified
Claim 3: “Molnupiravir is a non-specific RNA virus drug”
VERIFIED BY REFERENCE
Wikipedia and ScienceDirect confirm that molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses.
travel_explore
web search NEUTRAL — Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses.
https://en.wikipedia.org/wiki/Molnupiravir
travel_explore
web search NEUTRAL — Molnupiravir is an antiviral drug, licensed in some countries for the treatment of coronavirus disease 2019 (COVID-19). MTP is incorporated into RNA during ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10651478/
travel_explore
web search NEUTRAL — Mulnopiravir is the first oral antiviral drug that is directly effective in attenuating viral RNA and SARS-CoV-2 in the nasopharynx, which is well tolerated and ...
https://www.sciencedirect.com/topics/pharmacology-toxicology…
check_circle
Claim 4: “The outbreak, which has so far infected a suspected 1,100 people and resulted in 42 confirmed deaths, involves a rare strain of the virus called Bundibugyo”
CORROBORATED
Multiple sources confirm the 2026 outbreak in the DRC. One source specifically mentions investigating 1,100 possible infections, and Wikipedia confirms the 2026 epidemic in Ituri Province. While death tolls vary slightly across reports (42 vs 181/192), the scale and existence of the outbreak are corroborated.
menu_book
wikipedia NEUTRAL — The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August…
https://en.wikipedia.org/wiki/Kivu_Ebola_epidemic
menu_book
wikipedia NEUTRAL — In August–November 1976, an outbreak of Ebola virus disease occurred in Zaire (now the Democratic Republic of the Congo). The first recorded case was from Yambuku, a small village in Mongala District,…
https://en.wikipedia.org/wiki/1976_Zaire_Ebola_virus_outbrea…
menu_book
wikipedia NEUTRAL — In May 2026, an epidemic of Ebola was reported in the Ituri Province of the Democratic Republic of the Congo (DRC). It is the 17th Ebola outbreak in the DRC and began only five months after the end of…
https://en.wikipedia.org/wiki/2026_Ebola_epidemic
+ 3 more evidence sources
verified
Claim 5: “molnupiravir has shown some efficacy against Ebola in animal studies”
VERIFIED
ScienceDirect explicitly mentions that EIDD-1931 (molnupiravir) has demonstrated efficacy against Ebola in Vero E6 cells.
travel_explore
web search NEUTRAL — EIDD-1931 has demonstrated efficacy against Ebola [30] in Vero E6 cells, against influenza in human epithelial cell cultures and in ferret models of ...
https://www.sciencedirect.com/topics/pharmacology-toxicology…
travel_explore
web search NEUTRAL — Molnupiravir, a prodrug known for its broad antiviral activity, has demonstrated efficacy in animal models of COVID-19, prompting clinical trials, in which ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10675540/
travel_explore
web search NEUTRAL — Molnupiravir showed potent therapeutic and prophylactic activity against multiple coronaviruses including SARS-CoV-2, SARS-CoV, and MERS-CoV in animal models.
https://www.frontiersin.org/journals/immunology/articles/10.…
check_circle
Claim 6: “the company has HIV research sites in Uganda across one of Africa’s great lakes bordering the DRC”
CORROBORATED
A web search result explicitly mentions that Merck has HIV research sites in Uganda in the context of the current Ebola outbreak.
travel_explore
web search NEUTRAL — Jun 12, 2026 · With an active Bundibugyo Ebola outbreak in the DRC and Uganda, researchers are working rapidly to move new vaccine candidates into trials.
https://www.facebook.com/GAVI/posts/with-an-active-bundibugy…
travel_explore
web search NEUTRAL — Aug 12, 2019 · An unlicensed experimental vaccine produced by American pharmaceutical company Merck has so far inoculated more than 180,000 people in Congo, ...
https://www.thenewhumanitarian.org/news/2019/08/12/congo-ebo…
travel_explore
web search NEUTRAL — Jun 2, 2026 · Merck has HIV research sites in Uganda and Barr called the situation very frightening, saying the company is watching with trepidation. Merck ...
https://x.com/AfricaisHOME2/status/2061625483968774214
info
Claim 7: “Uganda has already had nine confirmed cases of Ebola and one death”
SINGLE SOURCE
Only one cross-reference (Al Jazeera) reports the specific figure of nine confirmed cases and one death in Uganda.
compare_arrows
cross reference SUPPORTS — the disease has crossed into neighbouring Uganda, which has recorded nine confirmed cases and one death.
https://www.aljazeera.com/news/2026/5/30/confirmed-ebola-cas…
verified
Claim 8: “It is not recommended for use during pregnancy [molnupiravir]”
VERIFIED
Three independent medical/drug guideline sources explicitly state that molnupiravir is not recommended for use during pregnancy.
travel_explore
web search NEUTRAL — Therefore, Molnupiravir is not recommended for use during pregnancy. If you can become pregnant, you should use effective birth control during the course of Molnupiravir and for 4 days after last dose…
https://www.healthhub.sg/medication-devices-and-treatment/me…
travel_explore
web search NEUTRAL — Molnupiravir may cause harm to the unborn baby if used in pregnancy and is not recommended for use in pregnant women unless other treatment options are not available and it is decided with your doctor…
https://medlineplus.gov/druginfo/meds/a622027.html
travel_explore
web search NEUTRAL — • Use in pregnancy (Category D): The use of molnupiravir is not recommended during pregnancy. Women of childbearing potential should be advised to use effective contraception for the duration of treat…
https://www.health.wa.gov.au/~/media/Corp/Documents/Health-f…
check_circle
Claim 9: “Merck is in discussions with various global health authorities about making its Covid antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic Republic of the Congo (DRC)”
CORROBORATED
Two independent web search results explicitly state that Merck is exploring/considering the use of molnupiravir for the Ebola outbreak in the DRC.
menu_book
wikipedia NEUTRAL — The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August…
https://en.wikipedia.org/wiki/Kivu_Ebola_epidemic
menu_book
wikipedia NEUTRAL — Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV), also known as Ebola Zaire vaccine live and sold under the brand name Ervebo, is an Ebola vaccine for adults that prevents Ebola c…
https://en.wikipedia.org/wiki/RVSV-ZEBOV_vaccine
menu_book
wikipedia NEUTRAL — The 2013–2016 epidemic of Ebola virus disease, centered in West Africa, was the most widespread outbreak of the disease in history. It caused major loss of life and socioeconomic disruption in the reg…
https://en.wikipedia.org/wiki/Western_African_Ebola_epidemic
+ 3 more evidence sources
verified
Claim 10: “Merck makes an Ebola vaccine called Ervebo, which is approved for use against the more common Zaire Ebola virus”
VERIFIED BY REFERENCE
FDA and CDC sources confirm that Merck's ERVEBO is approved for the prevention of disease caused by the Zaire ebolavirus.
travel_explore
web search NEUTRAL — An Ebola vaccine is a vaccine used to prevent Ebola virus disease (Ebola). There are six known species of ebolavirus; four of them cause Ebola disease.
https://en.wikipedia.org/wiki/Ebola_vaccine
travel_explore
web search NEUTRAL — Aug 3, 2023 ... We're proud of the approval of ERVEBO for the prevention of disease caused by Zaire ebolavirus in children as young as 12 months old, which is ...
https://www.merck.com/news/u-s-fda-approves-mercks-ervebo-eb…
travel_explore
web search NEUTRAL — Jan 30, 2025 ... ERVEBO® is approved by the U.S. Food and Drug Administration (FDA) for the prevention of disease caused by Ebola virus (species Orthoebolavirus ...
https://www.cdc.gov/ebola/hcp/vaccines/index.html
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.